President Donald Trump on Tuesday announced a deal with Pfizer to sell its drugs at lower prices to Medicaid patients.

Pfizer will now sell some drugs on a “direct to consumer” website called “TrumpRx,” which would be operated by the federal government.

The deal struck between the Trump administration and Pfizer will give the pharmaceutical manufacturer a three-year grace period on Trump’s planned tariffs on pharmaceuticals made outside the country, which will take effect Wednesday.

NBC News reported:

The agreement on lower prices will cover “a large majority” of Pfizer’s primary care medicines, along with speciality brand-name drugs, which will be offered at discounts averaging 50% and reaching as high as 85%, a spokesperson for the company said.

That includes Pfizer’s menopause dr

See Full Page